Intuitive Surgical, Inc. (ISRG)
ISRG Stock Price Chart
Explore Intuitive Surgical, Inc. interactive price chart. Choose custom timeframes to analyze ISRG price movements and trends.
ISRG Company Profile
Discover essential business fundamentals and corporate details for Intuitive Surgical, Inc. (ISRG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
16 Jun 2000
Employees
15.64k
Website
https://www.intuitive.comCEO
David J. Rosa
Description
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
ISRG Financial Timeline
Browse a chronological timeline of Intuitive Surgical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 20 Oct 2026
EPS estimate is $2.59, while revenue estimate is $2.90bn.
Earnings released on 16 Jul 2026
EPS came in at $2.80 surpassing the estimated $2.48 by +12.90%, while revenue for the quarter reached $2.89bn , beating expectations by +2.37%.
Earnings released on 21 Apr 2026
EPS came in at $2.80 surpassing the estimated $2.51 by +11.55%, while revenue for the quarter reached $2.77bn , beating expectations by +5.81%.
Earnings released on 22 Jan 2026
EPS came in at $2.53 surpassing the estimated $2.27 by +11.45%, while revenue for the quarter reached $2.87bn , beating expectations by +3.75%.
Earnings released on 21 Oct 2025
EPS came in at $2.40 surpassing the estimated $1.99 by +20.60%, while revenue for the quarter reached $2.51bn , beating expectations by +4.10%.
Earnings released on 22 Jul 2025
EPS came in at $2.19 surpassing the estimated $1.93 by +13.47%, while revenue for the quarter reached $2.44bn , beating expectations by +3.77%.
Earnings released on 22 Apr 2025
EPS came in at $1.81 surpassing the estimated $1.74 by +4.02%, while revenue for the quarter reached $2.25bn , beating expectations by +3.09%.
Earnings released on 23 Jan 2025
EPS came in at $2.21 surpassing the estimated $1.76 by +25.57%, while revenue for the quarter reached $2.41bn , beating expectations by +7.32%.
Earnings released on 17 Oct 2024
EPS came in at $1.84 surpassing the estimated $1.63 by +12.88%, while revenue for the quarter reached $2.04bn , beating expectations by +1.63%.
Earnings released on 18 Jul 2024
EPS came in at $1.78 surpassing the estimated $1.54 by +15.58%, while revenue for the quarter reached $2.01bn , beating expectations by +1.94%.
Earnings released on 18 Apr 2024
EPS came in at $1.50 surpassing the estimated $1.41 by +6.38%, while revenue for the quarter reached $1.89bn , beating expectations by +1.09%.
Earnings released on 23 Jan 2024
EPS came in at $1.60 surpassing the estimated $1.48 by +8.11%, while revenue for the quarter reached $1.93bn , beating expectations by +2.11%.
Earnings released on 19 Oct 2023
EPS came in at $1.46 surpassing the estimated $1.41 by +3.55%, while revenue for the quarter reached $1.74bn , missing expectations by -1.32%.
Earnings released on 20 Jul 2023
EPS came in at $1.42 surpassing the estimated $1.33 by +6.77%, while revenue for the quarter reached $1.76bn , beating expectations by +1.07%.
Earnings released on 18 Apr 2023
EPS came in at $1.23 surpassing the estimated $1.20 by +2.50%, while revenue for the quarter reached $1.70bn , beating expectations by +6.30%.
Earnings released on 24 Jan 2023
EPS came in at $1.23 falling short of the estimated $1.26 by -2.38%, while revenue for the quarter reached $1.66bn , missing expectations by -0.89%.
Earnings released on 18 Oct 2022
EPS came in at $1.19 surpassing the estimated $1.10 by +8.18%, while revenue for the quarter reached $1.56bn , beating expectations by +2.21%.
Earnings released on 21 Jul 2022
EPS came in at $1.14 falling short of the estimated $1.16 by -1.72%, while revenue for the quarter reached $1.52bn , missing expectations by -2.46%.
Earnings released on 21 Apr 2022
EPS came in at $1.13 surpassing the estimated $1.08 by +4.63%, while revenue for the quarter reached $1.49bn , beating expectations by +4.36%.
Earnings released on 20 Jan 2022
EPS came in at $1.30 surpassing the estimated $1.28 by +1.56%, while revenue for the quarter reached $1.55bn , beating expectations by +1.92%.
Earnings released on 19 Oct 2021
EPS came in at $1.19 surpassing the estimated $1.17 by +1.71%, while revenue for the quarter reached $1.40bn , beating expectations by +0.79%.
Stock split effective on 5 Oct 2021
Shares were split 3 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 20 Jul 2021
EPS came in at $1.31 surpassing the estimated $1.05 by +24.76%, while revenue for the quarter reached $1.46bn , beating expectations by +5.15%.
ISRG Stock Performance
Access detailed ISRG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
